Against this backdrop, a team led by Professor Zhang Han and Associate Professor Chen Zhi from Shenzhen University in China , has demonstrated an innovative approach that combines DNA origami, CRISPR ...
A phase II study of erlotinib plus capecitabine (XEL) as first-line treatment for elderly patients (pts) with advanced adenocarcinoma of lung (ML 22206 study). Background: Detecting epidermal growth ...
WT1 to enhance proliferation and to impede apoptosis in KRAS-mutant NSCLC via targeting cMyc. This is an ASCO Meeting Abstract from the 2015 ASCO Annual Meeting I. This abstract does not include a ...
Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its effectiveness is often limited by the extremely low levels of tumor-derived DNA ...
Genetic mutations cause hundreds of unsolved and untreatable disorders. Among them, DNA mutations in a small percentage of cells, called mosaic mutations, are extremely difficult to detect because ...
A microfluidic device barely larger than a U.S. quarter and developed by a Rutgers University-led team can detect rare genetic mutations from a single drop of blood. A team led by Rutgers ...
As new variants of the SARS-CoV-2 virus continue to emerge, concerns have been raised about the performance of rapid antigen tests. The team, which was funded by NIH's Rapid Acceleration of ...
Bryan Tieman is a Principal Scientist in the Diagnostics Division of Abbott Laboratories (IL, USA) and is a member of the Biologics Discovery Group where he creates binding agents and targets for the ...
Using the LightCycler 480 System for Discovery and Analysis of Genetic Variation LightCycler® Real-time PCR Systems from Roche (www.roche.com) are efficient platforms for genetic variation research.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results